Rapport Therapeutics Bolsa (NASDAQ: RAPP)

Rapport Therapeutics (NASDAQ:RAPP) Bolsa

Rapport Therapeutics

Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.

Sportsman'sSaratoga,Springs,,Utah,,Usa,-,Nov,30,,2024:,Sportsman's,Warehouse

AEHL

AGMH

BIAF

DGLY

GRFS

NCNO

NMAX

QUAD

RAPP

RSLS

SAMG

SBFM

SPWH

STSS

SYRA

Sportsman&#39;s Warehouse sorprende con ingresos y ganancias inesperadas: conoce las cifras que hicieron subir sus acciones.

Acciones de Sportsman&#39;s Warehouse (SPWH) se disparan un 39%; Aquí están 20 acciones moviéndose en premercado

GameStop Corp.

News

Pre-Market Outlook

Markets

Movers

Trading Ideas

BHIL

BSGM

CISO

CLEU

GDHG

HUMA

IMTE

NYXH

ORKA

PTPI

SURG

THTX

TXMD

WINT

ZYBT

El premercado de hoy revela fuertes movimientos bursátiles tras informes financieros y aprobaciones clave en sectores críticos.

Las acciones de GameStop (GME) suben alrededor del 13%; Aquí están 20 acciones que se mueven en el premercado

Rapport Therapeutics, Inc. - Common Stock

Rapport Therapeutics Inc

Needham analyst Mike Cikos maintained a Buy rating on Zscaler (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZS#NASDAQ">ZS</a>) and raised the price <a target="_blank" href="https://www.benzinga.com/quote/ZS/analyst-ratings" rel="noreferrer noopener">forecast from&nbsp;$310&nbsp;to&nbsp;$350</a>.
On June 3, Cikos attended Zscaler&#8217;s annual Zenith event, the company&#8217;s flagship gathering for customers and partners. In an analyst note, he said that the company unveiled several new capabilities, primarily focused on AI and the expansion of its <a target="_blank" href="https://www.benzinga.com/pressreleases/25/06/g45743698/zscaler-unveils-cutting-edge-ai-innovations-to-stop-attacks-protect-sensitive-data-and-enable-busi" rel="noreferrer noopener">Zero Trust Everywhere initiative</a>.
These enhancements aim to bolster data security and thwart cyberattacks, directly addressing critical challenges businesses face when adopting AI, such as protecting proprietary information and ensuring regulatory compliance.
Also Read: <a target="_blank" href="https://www.benzinga.com//node/45683134" rel="noreferrer noopener">Zscaler Beats Q3 Earnings Estimates, Raises Guidance, Increases Investments In AI</a>
Cikos stated that he sees Zenith as Zscaler&#8217;s initial presentation of management&#8217;s expansive vision for a reimagined Agentic SOC (Security Operations Center) powered by AI innovations supporting their Data Fabric for Security.
Concurrently, the acquisition of Red Canary is expected to accelerate this vision by adding domain experts capable of engaging with customer SOC teams, a slightly different client persona, the analyst noted.
Additionally, the analyst pointed out that Red Canary is anticipated to empower Zscaler&#8217;s partners to serve clients better while advancing the Threat Management vision by more effectively utilizing security signals for investigations.
The analyst believes that Zscaler is capable of maintaining its high level of execution as new sales hires increase their productivity and attrition rates decline.
Cikos mentioned that in the third quarter of FY25, Zero Trust Everywhere customers grew over 60% sequentially to more than 210, targeting over 390 by the end of FY26.
The company sees a 6x up/cross-sell opportunity in existing customers, and Cikos views newer products like Branch and AI Analytics as underappreciated.
Cikos foresees sustained ~20% growth, with operating margins eventually surpassing 30% in the long term.
Price Action: ZS shares are trading higher by 1.05% to $298.19&nbsp;at last check Wednesday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst-color/25/05/45699987/zscaler-stock-jumps-on-q3-report-another-strong-quarter-company-did-not-experience-any-noticeable-impact-from-tariffs" target="_blank" rel="noreferrer noopener">Zscaler Stock Jumps On Q3 Report: &#8216;Another Strong Quarter,&#8217; Company Did Not Experience Any &#8216;Noticeable Impact&#8217; From Tariffs</a></li>
</ul>
Photo by Sundry Photography via Shutterstock

Analyst Color

Price Target

Reiteration

Analyst Ratings

Red Canary Acquisition, AI Innovations Propel Zscaler's Growth Story: Analyst

<a href="https://www.reuters.com/sustainability/rio-tinto-revising-cost-serbia-lithium-project-2025-06-04/" title="https://www.reuters.com/sustainability/rio-tinto-revising-cost-serbia-lithium-project-2025-06-04/">https://www.reuters.com/sustainability/rio-tinto-revising-cost-serbia-lithium-project-2025-06-04/</a>

Reported Earlier: "Rio Tinto Revising Cost Of Serbia Lithium Project" - Reuters News

<a href="https://hackread.com/hackers-leak-86m-att-records-with-decrypted-ssns/" title="https://hackread.com/hackers-leak-86m-att-records-with-decrypted-ssns/">https://hackread.com/hackers-leak-86m-att-records-with-decrypted-ssns/</a>

'Exclusive: Hackers Leak 86 Million AT&T Records with Decrypted SSNs' - HackRead

While <a href="https://www.benzinga.com/topic/donald-trump">President Donald Trump</a> took to Truth Social and <a href="https://truthsocial.com/@realDonaldTrump/posts/114623644825050017">declared</a> May "the best in 30 years," Wall Street's AI infrastructure darlings were busy scripting their own version of greatness. CoreWeave Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWV#NASDAQ">CRWV</a>), Credo Technology Group Holding Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRDO#NASDAQ">CRDO</a>) and Cloudflare Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NET#NYSE">NET</a>) emerged as the month's stealth tech titans &#8211; each riding the AI infrastructure boom to outsized gains.
Leading the charge was CoreWeave, a software infrastructure company turned market sensation, soaring a staggering +191.80% in May. With a year-to-date gain of over 276%, CoreWeave's explosive rally was backed by strong stock price momentum and a blistering RSI (relative strength index) of 79.48 &#8211; clear signals of momentum traders piling in.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0604"><img loading="lazy" decoding="async" width="631" height="486" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/04094607/Screenshot-2025-06-04-at-7.15.38-PM.png" alt="" class="wp-image-938298" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/04094607/Screenshot-2025-06-04-at-7.15.38-PM.png 631w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/04094607/Screenshot-2025-06-04-at-7.15.38-PM-300x231.png 300w" sizes="(max-width: 631px) 100vw, 631px" /></a></figure>
<a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0604" target="_blank" rel="noreferrer noopener">Chart created Benzinga Pro</a>
With price action blasting through its 20-day and 50-day moving averages by 70% and 137% respectively, the chart screams overextended &#8211; but try telling that to the bulls who just saw the stock break through resistance like it wasn't even there.
Read Also: <a href="https://www.benzinga.com/trading-ideas/movers/25/06/45774434/coreweave-applied-digital-shares-are-trending-wednesday-whats-going-on">CoreWeave, Applied Digital Shares Are Trending Wednesday: What&#8217;s Going On?</a>
Credo Technology, a semiconductor firm tied to the data movement backbone of AI infrastructure, also crushed it with a +49.03% monthly gain, buoyed by a quarterly performance of +32.40%. 
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0604"><img loading="lazy" decoding="async" width="631" height="486" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/04094800/Screenshot-2025-06-04-at-7.17.45-PM.png" alt="" class="wp-image-938302" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/04094800/Screenshot-2025-06-04-at-7.17.45-PM.png 631w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/04094800/Screenshot-2025-06-04-at-7.17.45-PM-300x231.png 300w" sizes="(max-width: 631px) 100vw, 631px" /></a></figure>
<a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0604" target="_blank" rel="noreferrer noopener">Chart created Benzinga Pro</a>
CRDO stock's RSI is high at 74.87, suggesting strength remains in the trend. With its 52-week range expanding over 219%, investors are re-rating the stock because they see it as a long-term bandwidth enabler in an AI-heavy world.
Not far behind, Cloudflare rounded out the AI trio with a 38.91% gain in May, bolstered by a remarkable 153.85% rise over the past year.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0604"><img loading="lazy" decoding="async" width="631" height="486" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/04094951/Screenshot-2025-06-04-at-7.19.36-PM.png" alt="" class="wp-image-938307" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/04094951/Screenshot-2025-06-04-at-7.19.36-PM.png 631w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/04094951/Screenshot-2025-06-04-at-7.19.36-PM-300x231.png 300w" sizes="(max-width: 631px) 100vw, 631px" /></a></figure>
<a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0604" target="_blank" rel="noreferrer noopener">Chart created Benzinga Pro</a>
Known for its role in secure, scalable internet infrastructure, Cloudflare's steady momentum continues with low volatility and a bullish RSI of 84.85 &#8211; territory typically reserved for runaway winners.
In a market driven by artificial intelligence dreams and infrastructure needs, these three stocks aren't just riding a wave &#8211; they're helping build the surfboard. 
Trump may be talking macro, but CoreWeave, Credo and Cloudflare just proved that in the AI arms race, infrastructure is where the real money is made.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/technicals/25/06/45769560/crwv-stock-hits-new-all-time-high-on-7-billion-apld-deal-technical-indicators-flash-bullish-signal-but-rsi-warns-caution-on-coreweave">CRWV Stock Hits New All-Time High On $7 Billion APLD Deal: Technical Indicators Flash Bullish Signal, But RSI Warns Caution On CoreWeave</a></li>
</ul>
Photo: Shutterstock

Long Ideas

Technicals

Tech

CRDO

CRWV

Trump Hails 'Best May In 30 Years' — These 3 AI Infra Stocks Delivered Their Own MAGA Moment

Hims &amp; Hers Health, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HIMS#NYSE">HIMS</a>) on Tuesday agreed to acquire ZAVA, a European digital health platform. The deal <a target="_blank" href="https://www.benzinga.com/topic/weight-loss" rel="noreferrer noopener">terms were not disclosed</a>.
The acquisition consideration will be 100% cash, funded from the company&#8217;s balance sheet at closing. The acquisition is expected to close in the <a target="_blank" href="https://www.benzinga.com/pressreleases/25/06/b45742522/hims-hers-announces-plans-to-acquire-zava-accelerating-major-european-growth-across-the-uk-germany" rel="noreferrer noopener">second half of 2025</a>.
The move will expand Hims &amp; Hers&#8217; footprint in the United Kingdom and officially launch the company into Germany, France, and Ireland, with more markets anticipated soon.
In the coming quarters, Hims &amp; Hers will establish its own branded presence in these European markets, leveraging the ZAVA platform.
Also Read: <a target="_blank" href="https://www.benzinga.com//node/45412383" rel="noreferrer noopener">Hims &amp; Hers Stock Pulls Back After Strong Q1 Earnings, 115% Gain Over Past Month</a>
The deal will significantly strengthen Hims &amp; Hers&#8217; international footprint. Serving more than 1.3 million active customers, ZAVA&#8217;s in-house medical team delivered nearly 2.3 million consultations in 2024 across the U.K., Germany, France, and Ireland.
Hims &amp; Hers will soon introduce a new, personalized dimension of digital health in Europe, providing individuals with access to care tailored to their needs and goals across dermatology, weight loss, sexual health, and mental health. While Hims &amp; Hers will share more about the offerings and their rollout in the coming months, they expect the deal to be accretive by 2026.
&#8220;We are positively inclined by the deal and believe HIMS&#8217; existing solutions are highly applicable to similar demographics in Europe, underscoring the potential for international markets to be a durable growth vector longer term,&#8221; a Needham analyst wrote on Wednesday.
Analyst Ryan Macdonald reiterated the Buy rating for the stock, raising the <a target="_blank" href="https://www.benzinga.com/quote/HIMS/analyst-ratings" rel="noreferrer noopener">price forecast from $61 to $65</a>.
While HIMS did not disclose any financial metrics for ZAVA, Needham estimates ZAVA revenues in the range of $100 million annually.
&#8220;We conservatively estimate the weight loss opportunity alone in ZAVA&#8217;s existing markets to expand HIMS&#8217; Total Addressable Market by $52.1 billion,&#8221; analyst Macdonald wrote.
Price Action: HIMS stock is down 2.24% at $53.51&nbsp;at the last check on Wednesday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/health-care/25/06/45768319/sagimets-partner-achieves-positive-results-with-oral-acne-drug-in-phase-3-acne-trial-in-china-stock-jumps" target="_blank" rel="noreferrer noopener">Sagimet&#8217;s Partner Achieves Positive Results With Oral Acne Drug In Phase 3 Trial In China, Stock Jumps</a></li>
</ul>
Image by T. Schneider via Shutterstock

Health Care

General

Hims & Hers Health, Inc. Class A Common Stock

HIMS

Hims & Hers ZAVA Acquisition Deal Expands Its Market Opportunity By $52 Billion: Analyst

<a href="https://x.com/elonmusk/status/1930336497208832059" title="https://x.com/elonmusk/status/1930336497208832059">https://x.com/elonmusk/status/1930336497208832059</a>

Macro Economic Events

Politics

Economics

Elon Musk Posted On X "Call your Senator, Call your Congressman, Bankrupting America is NOT ok! KILL the BILL"

<a href="https://www.axios.com/pro/energy-policy/2025/06/04/senate-nuclear-and-geothermal-tax-credits" title="https://www.axios.com/pro/energy-policy/2025/06/04/senate-nuclear-and-geothermal-tax-credits">https://www.axios.com/pro/energy-policy/2025/06/04/senate-nuclear-and-geothermal-tax-credits</a>

Reported Earlier: "Senate Might Rescue Nuclear And Geothermal Tax Credits" - Axios Pro

<a href="https://techcrunch.com/2025/06/04/unity-cto-steve-collins-steps-down-after-six-months/" title="https://techcrunch.com/2025/06/04/unity-cto-steve-collins-steps-down-after-six-months/">https://techcrunch.com/2025/06/04/unity-cto-steve-collins-steps-down-after-six-months/</a>

Management

Reported Earlier: 'Unity CTO Steve Collins Steps Down After 6 Months' - Tech Crunch

Rosenblatt analyst Mike Genovese is questioning how successful Ciena (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CIEN#NYSE">CIEN</a>) will be over the next one to five years, taking on companies like Marvell Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRVL#NASDAQ">MRVL</a>) and Broadcom Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGO#NASDAQ">AVGO</a>).
What Happened: The analyst maintains <a href="https://www.benzinga.com/quote/CIEN/analyst-ratings" target="_blank" rel="noreferrer noopener">a Neutral</a> rating and raised the price target from $65 to $85, according to a Tuesday research note.
Ciena will report second-quarter results on June 5 before the open.
Genovese expects good results and guidance, likely slightly ahead of consensus, driven by substantial revenues and orders.
Ciena&#8217;s upcoming report comes as the market for transceivers and components changes. The proliferation of AI-focused data centers, for example, demands extremely high bandwidth.
Ciena uses Coherent lite optics — a lightweight, more cost-effective version of high-end coherent optics — and IM/DD (Intensity Modulation/Direct Detection).
The analyst questioned whether the company would increase fiscal 2025 revenue guidance from its current &#8220;high-end of 8% to 11%&#8221; range.
Also Read: <a href="https://www.benzinga.com/news/earnings/25/03/44245291/ciena-q1-earnings-revenue-and-eps-beat-estimates-ceo-eyes-ai-cloud-network-tailwinds" target="_blank" rel="noreferrer noopener">Ciena Q1 Earnings: Revenue and EPS Beat Estimates, CEO Eyes AI, Cloud Network Tailwinds</a>
Why It Matters: Genovese wonders whether the company will achieve mid-40s gross margins within the next three years and whether there is upside to mid-40s gross margins in 3 to 5 years if it successfully wins a share of AI Data Center campus, fabric, and cluster applications.
Genovese said Ciena sells Metro, LH, and Subsea Data Center Interconnect to every major U.S. Cloud Provider and Metro and LH Optical transport. U.S. Tier 1 Telco orders continue to be significantly higher than a year ago.
Second-quarter revenues should hover around $1.09 billion. That&#8217;s up 20% year over year versus an easy comp and up 2% quarter over quarter.
Genovese noted that Ciena could slightly exceed second-quarter revenue expectations. The company could also keep its backlog consistent with the prior quarter at ~$2.3 billion or grow its backlog due to strong orders. The consensus hurdles for gross margins, operating margins, and EPS are 42.6%, 10.0%, and $0.52, all of which look slightly beatable, he says.
DCI is Ciena&#8217;s primary market exposure. Genovese said the revenue mix shift keeps going toward Cloud Providers from Service Providers. The company&#8217;s heavy DCI exposure is unlikely to support mid-40s gross margins, he says.
According to the analyst, significant progress in generating inside-the-datacenter and software revenues will be needed to achieve sustainable mid-40s gross margins.
Price Action:&nbsp;CIEN stock is up 1.63% at $84.62 at last check Wednesday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst-color/25/06/45751360/broadcoms-flexes-ai-muscle-hyperscalers-buying-in" target="_blank" rel="noreferrer noopener">Broadcom Tomahawk 6 Flexes AI Muscle, Hyperscalers Are Buying In</a></li>
</ul>
Image: Shutterstock

AVGO

CIEN

MRVL

Ciena Set To Beat Q2 Estimates But AI Ambitions Face Margin Math And Marvell-ous Rivals

Financial giants have made a conspicuous bullish move on IREN. Our analysis of options history for IREN (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IREN#NASDAQ">IREN</a>) revealed 9 unusual trades.
Delving into the details, we found 77% of traders were bullish, while 22% showed bearish tendencies. Out of all the trades we spotted, 3 were puts, with a value of $240,331, and 6 were calls, valued at $380,758.
<h3>Expected Price Movements</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $8.0 to $20.0 for IREN over the recent three months. 
<h3>Volume &amp; Open Interest Development</h3>
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for IREN's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across IREN's significant trades, within a strike price range of $8.0 to $20.0, over the past month.
<h3>IREN Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1749063707_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>IREN</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>08/15/25</td>
<td>$0.2</td>
<td>$0.19</td>
<td>$0.19</td>
<td>$16.00</td>
<td>$113.7K</td>
<td>6.0K</td>
<td>6.0K</td>
</tr>
<tr>
<td>IREN</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/19/25</td>
<td>$3.55</td>
<td>$3.45</td>
<td>$3.45</td>
<td>$11.00</td>
<td>$103.1K</td>
<td>362</td>
<td>300</td>
</tr>
<tr>
<td>IREN</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$0.27</td>
<td>$0.26</td>
<td>$0.26</td>
<td>$9.50</td>
<td>$96.5K</td>
<td>1.6K</td>
<td>3.6K</td>
</tr>
<tr>
<td>IREN</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>03/20/26</td>
<td>$3.2</td>
<td>$3.1</td>
<td>$3.1</td>
<td>$10.00</td>
<td>$83.4K</td>
<td>15.7K</td>
<td>270</td>
</tr>
<tr>
<td>IREN</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>07/18/25</td>
<td>$0.83</td>
<td>$0.8</td>
<td>$0.83</td>
<td>$10.00</td>
<td>$83.0K</td>
<td>7.1K</td>
<td>5.8K</td>
</tr>
</tbody>
</table>

<h3>About IREN</h3>
IREN Ltd is engaged in data center business powering the future of Bitcoin, AI and beyond utilizing renewable energy.
Following our analysis of the options activities associated with IREN, we pivot to a closer look at the company's own performance.
<h3>Where Is IREN Standing Right Now?</h3>
<ul>
<li>Trading volume stands at 9,129,710, with IREN's price up by 6.58%, positioned at $9.47.</li>
<li>RSI indicators show the stock to be may be overbought.</li>
<li>Earnings announcement expected in 84 days.</li>
</ul>
<h3>What The Experts Say On IREN</h3>
4 market experts have recently issued ratings for this stock, with a consensus target price of $19.75.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; An analyst from HC Wainwright &amp; Co. has decided to maintain their Buy rating on IREN, which currently sits at a price target of $21. 
&#x2A; An analyst from Macquarie persists with their Outperform rating on IREN, maintaining a target price of $20. 
&#x2A; Consistent in their evaluation, an analyst from Canaccord Genuity keeps a Buy rating on IREN with a target price of $23. 
&#x2A; An analyst from B. Riley Securities persists with their Buy rating on IREN, maintaining a target price of $15. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest IREN options trades with real-time alerts from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.

Options

IREN

Market Whales and Their Recent Bets on IREN Options

Investors with a lot of money to spend have taken a bearish stance on Home Depot (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HD#NYSE">HD</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with HD, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://www.benzinga.com/pro/">Benzinga</a>'s options scanner spotted 15 uncommon options trades for Home Depot.
This isn't normal.
The overall sentiment of these big-money traders is split between 20% bullish and 53%, bearish.
Out of all of the special options we uncovered, 6 are puts, for a total amount of $359,730, and 9 are calls, for a total amount of $289,010.
<h3>Predicted Price Range</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $300.0 to $460.0 for Home Depot over the last 3 months. 
<h3>Insights into Volume &amp; Open Interest</h3>
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for Home Depot's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Home Depot's whale activity within a strike price range from $300.0 to $460.0 in the last 30 days. 
<h3>Home Depot 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1749063702_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>HD</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/17/27</td>
<td>$54.75</td>
<td>$54.05</td>
<td>$54.75</td>
<td>$390.00</td>
<td>$136.8K</td>
<td align="right">3</td>
<td align="right">25</td>
</tr>
<tr>
<td>HD</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>08/15/25</td>
<td>$4.95</td>
<td>$4.9</td>
<td>$4.95</td>
<td>$345.00</td>
<td>$95.5K</td>
<td align="right">601</td>
<td align="right">244</td>
</tr>
<tr>
<td>HD</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$17.35</td>
<td>$17.25</td>
<td>$17.25</td>
<td>$400.00</td>
<td>$43.1K</td>
<td align="right">844</td>
<td align="right">25</td>
</tr>
<tr>
<td>HD</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>09/19/25</td>
<td>$16.35</td>
<td>$16.1</td>
<td>$16.18</td>
<td>$380.00</td>
<td>$40.4K</td>
<td align="right">901</td>
<td align="right">61</td>
</tr>
<tr>
<td>HD</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>06/20/25</td>
<td>$74.2</td>
<td>$71.35</td>
<td>$72.78</td>
<td>$300.00</td>
<td>$36.3K</td>
<td align="right">193</td>
<td align="right">5</td>
</tr>
</tbody>
</table>

<h3>About Home Depot</h3>
Home Depot is the world's largest home improvement specialty retailer, operating 2,350 warehouse-format stores offering more than 30,000 products in store and 1 million products online in the US, Canada, and Mexico. Its stores offer building materials, home improvement products, lawn and garden products, and decor products and provide various services, including home improvement installation services and tool and equipment rentals. The acquisition of Interline Brands in 2015 allowed Home Depot to enter the MRO business, which has been expanded through the tie-up with HD Supply (2020). The additions of the Company Store brought textiles to the lineup, and the 2024 tie-up with SRS will help grow professional demand in roofing, pool and landscaping projects.
<h3>Current Position of Home Depot</h3>
<ul>
<li>Trading volume stands at 1,460,051, with HD's price up by 0.21%, positioned at $373.88.</li>
<li>RSI indicators show the stock to be may be approaching overbought.</li>
<li>Earnings announcement expected in 69 days.</li>
</ul>
<h3>Expert Opinions on Home Depot</h3>
In the last month, 5 experts released ratings on this stock with an average target price of $431.6.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; An analyst from Guggenheim has revised its rating downward to Buy, adjusting the price target to $450. 
&#x2A; Maintaining their stance, an analyst from Telsey Advisory Group continues to hold a Outperform rating for Home Depot, targeting a price of $455. 
&#x2A; An analyst from Stifel upgraded its action to Buy with a price target of $425. 
&#x2A; Consistent in their evaluation, an analyst from JP Morgan keeps a Overweight rating on Home Depot with a target price of $418. 
&#x2A; An analyst from JP Morgan persists with their Overweight rating on Home Depot, maintaining a target price of $410. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Home Depot with <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> for real-time alerts.

Spotlight on Home Depot: Analyzing the Surge in Options Activity

Deep-pocketed investors have adopted a bullish approach towards JPMorgan Chase (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JPM#NYSE">JPM</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in JPM usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 8 extraordinary options activities for JPMorgan Chase. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 37% leaning bullish and 37% bearish. Among these notable options, 3 are puts, totaling $271,488, and 5 are calls, amounting to $258,664.
<h3>Predicted Price Range</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $245.0 to $270.0 for JPMorgan Chase during the past quarter. 
<h3>Insights into Volume &amp; Open Interest</h3>
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for JPMorgan Chase's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across JPMorgan Chase's significant trades, within a strike price range of $245.0 to $270.0, over the past month.
<h3>JPMorgan Chase Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1749063697_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>JPM</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$11.55</td>
<td>$11.35</td>
<td>$11.45</td>
<td>$245.00</td>
<td>$114.5K</td>
<td>768</td>
<td align="right">100</td>
</tr>
<tr>
<td>JPM</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>08/15/25</td>
<td>$9.5</td>
<td>$9.45</td>
<td>$9.45</td>
<td>$270.00</td>
<td>$111.5K</td>
<td>1.3K</td>
<td align="right">123</td>
</tr>
<tr>
<td>JPM</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>08/15/25</td>
<td>$10.7</td>
<td>$10.6</td>
<td>$10.6</td>
<td>$265.00</td>
<td>$97.5K</td>
<td>826</td>
<td align="right">173</td>
</tr>
<tr>
<td>JPM</td>
<td>PUT</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>09/19/25</td>
<td>$15.0</td>
<td>$14.8</td>
<td>$14.93</td>
<td>$270.00</td>
<td>$59.4K</td>
<td>387</td>
<td align="right">63</td>
</tr>
<tr>
<td>JPM</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>09/19/25</td>
<td>$12.2</td>
<td>$12.05</td>
<td>$12.2</td>
<td>$270.00</td>
<td>$48.8K</td>
<td>1.5K</td>
<td align="right">65</td>
</tr>
</tbody>
</table>

<h3>About JPMorgan Chase</h3>
JPMorgan Chase is one of the largest and most complex financial institutions in the United States, with nearly $4 trillion in assets. It is organized into four major segments: consumer and community banking, corporate and investment banking, commercial banking, and asset and wealth management. JPMorgan operates, and is subject to regulation, in multiple countries.
<h3>JPMorgan Chase's Current Market Status</h3>
<ul>
<li>Trading volume stands at 3,319,674, with JPM's price down by -0.59%, positioned at $264.7.</li>
<li>RSI indicators show the stock to be may be approaching overbought.</li>
<li>Earnings announcement expected in 41 days.</li>
</ul>
<h3>Expert Opinions on JPMorgan Chase</h3>
A total of 5 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $282.2.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; An analyst from TD Securities persists with their Buy rating on JPMorgan Chase, maintaining a target price of $315. 
&#x2A; Consistent in their evaluation, an analyst from Piper Sandler keeps a Overweight rating on JPMorgan Chase with a target price of $295. 
&#x2A; An analyst from Morgan Stanley has decided to maintain their Equal-Weight rating on JPMorgan Chase, which currently sits at a price target of $236. 
&#x2A; An analyst from Truist Securities has decided to maintain their Hold rating on JPMorgan Chase, which currently sits at a price target of $280. 
&#x2A; Maintaining their stance, an analyst from RBC Capital continues to hold a Outperform rating for JPMorgan Chase, targeting a price of $285. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for JPMorgan Chase with <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> for real-time alerts.

Smart Money Is Betting Big In JPM Options

19 analysts have expressed a variety of opinions on U.S. Bancorp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/USB#NYSE">USB</a>) over the past quarter, offering a diverse set of opinions from bullish to bearish.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">3</td>
<td align="right">10</td>
<td align="right">5</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">8</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $50.45, a high estimate of $59.00, and a low estimate of $43.50. Observing a downward trend, the current average is 7.24% lower than the prior average price target of $54.39. 
<img src="https://www.benzinga.com/files/images/story/2025/1749063686_0.png" alt="price target chart" />
<h2>Analyzing Analyst Ratings: A Detailed Breakdown</h2>
In examining recent analyst actions, we gain insights into how financial experts perceive U.S. Bancorp. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Vijay Kumar</td>
<td>Evercore ISI Group</td>
<td>Raises</td>
<td>In-Line</td>
<td>$49.00</td>
<td>$44.00</td>
</tr>
<tr>
<td>Chris Kotowski</td>
<td>Oppenheimer</td>
<td>Raises</td>
<td>Outperform</td>
<td>$59.00</td>
<td>$57.00</td>
</tr>
<tr>
<td>Peter Winter</td>
<td>DA Davidson</td>
<td>Lowers</td>
<td>Buy</td>
<td>$49.00</td>
<td>$54.00</td>
</tr>
<tr>
<td>Michael Rose</td>
<td>Raymond James</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$51.00</td>
<td>$57.00</td>
</tr>
<tr>
<td>Scott Siefers</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$48.00</td>
<td>$49.00</td>
</tr>
<tr>
<td>Gerard Cassidy</td>
<td>RBC Capital</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$50.00</td>
<td>$57.00</td>
</tr>
<tr>
<td>Betsy Graseck</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$50.00</td>
<td>$51.00</td>
</tr>
<tr>
<td>Mike Mayo</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$50.00</td>
<td>$56.00</td>
</tr>
<tr>
<td>Jason Goldberg</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$56.00</td>
<td>$61.00</td>
</tr>
<tr>
<td>John McDonald</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Hold</td>
<td>$48.00</td>
<td>$51.00</td>
</tr>
<tr>
<td>David Konrad</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Lowers</td>
<td>Market Perform</td>
<td>$49.00</td>
<td>$54.00</td>
</tr>
<tr>
<td>Betsy Graseck</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$51.00</td>
<td>$55.00</td>
</tr>
<tr>
<td>John McDonald</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Hold</td>
<td>$51.00</td>
<td>$54.00</td>
</tr>
<tr>
<td>Bill Carcache</td>
<td>Wolfe Research</td>
<td>Announces</td>
<td>Outperform</td>
<td>$49.00</td>
<td>-</td>
</tr>
<tr>
<td>Vivek Juneja</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Underweight</td>
<td>$43.50</td>
<td>$51.00</td>
</tr>
<tr>
<td>Mike Mayo</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$56.00</td>
<td>$62.00</td>
</tr>
<tr>
<td>Keith Horowitz</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Buy</td>
<td>$55.00</td>
<td>$65.00</td>
</tr>
<tr>
<td>Richard Ramsden</td>
<td>Goldman Sachs</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$45.00</td>
<td>$51.00</td>
</tr>
<tr>
<td>Ebrahim Poonawala</td>
<td>B of A Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$49.00</td>
<td>$50.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to U.S. Bancorp. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of U.S. Bancorp compared to the broader market.</li>
<li>Price Targets: Understanding forecasts, analysts offer estimates for U.S. Bancorp's future value. Examining the current and prior targets provides insight into analysts' changing expectations.</li>
</ul>
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into U.S. Bancorp's market standing. Stay informed and make well-considered decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/USB/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on U.S. Bancorp analyst ratings.</a>
<h2>About U.S. Bancorp</h2>
With assets of around $680 billion, U.S. Bancorp is one of the largest regional banks in the US with its footprint in 26 states. The bank's branch network is mostly in midwestern and western markets. U.S. Bancorp has a comprehensive product set, with offerings in retail and commercial banking, credit cards, mortgages, payment services, trust, and wealth services.
<h3>Key Indicators: U.S. Bancorp's Financial Health</h3>
Market Capitalization Analysis: The company exhibits a lower market capitalization profile, positioning itself below industry averages. This suggests a smaller scale relative to peers.
Revenue Growth: Over the 3M period, U.S. Bancorp showcased positive performance, achieving a revenue growth rate of 3.64% as of 31 March, 2025. This reflects a substantial increase in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Financials sector.
Net Margin: U.S. Bancorp's net margin is impressive, surpassing industry averages. With a net margin of 23.14%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): U.S. Bancorp's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 3.05% ROE, the company effectively utilizes shareholder equity capital.
Return on Assets (ROA): U.S. Bancorp's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of 0.24%, the company may face hurdles in achieving optimal financial returns.
Debt Management: U.S. Bancorp's debt-to-equity ratio is below the industry average. With a ratio of 1.45, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
<h2>Analyst Ratings: Simplified</h2>
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Demystifying U.S. Bancorp: Insights From 19 Analyst Reviews

During the last three months, 20 analysts shared their evaluations of Walmart (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WMT#NYSE">WMT</a>), revealing diverse outlooks from bullish to bearish.
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">4</td>
<td align="right">14</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">3</td>
<td align="right">6</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">6</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
In the assessment of 12-month price targets, analysts unveil insights for Walmart, presenting an average target of $105.6, a high estimate of $117.00, and a low estimate of $91.00. Experiencing a 1.01% decline, the current average is now lower than the previous average price target of $106.68. 
<img src="https://www.benzinga.com/files/images/story/2025/1749063678_0.png" alt="price target chart" />
<h2>Interpreting Analyst Ratings: A Closer Look</h2>
The perception of Walmart by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Greg Melich</td>
<td>Evercore ISI Group</td>
<td>Raises</td>
<td>Outperform</td>
<td>$107.00</td>
<td>$105.00</td>
</tr>
<tr>
<td>Scot Ciccarelli</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$111.00</td>
<td>$107.00</td>
</tr>
<tr>
<td>Steven Shemesh</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$102.00</td>
<td>$102.00</td>
</tr>
<tr>
<td>Joseph Feldman</td>
<td>Telsey Advisory Group</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$115.00</td>
<td>$115.00</td>
</tr>
<tr>
<td>Michael Baker</td>
<td>DA Davidson</td>
<td>Maintains</td>
<td>Buy</td>
<td>$117.00</td>
<td>$117.00</td>
</tr>
<tr>
<td>Peter Benedict</td>
<td>Baird</td>
<td>Raises</td>
<td>Outperform</td>
<td>$110.00</td>
<td>$100.00</td>
</tr>
<tr>
<td>Joseph Feldman</td>
<td>Telsey Advisory Group</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$115.00</td>
<td>$115.00</td>
</tr>
<tr>
<td>Rupesh Parikh</td>
<td>Oppenheimer</td>
<td>Raises</td>
<td>Outperform</td>
<td>$110.00</td>
<td>$100.00</td>
</tr>
<tr>
<td>Scot Ciccarelli</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$107.00</td>
<td>$111.00</td>
</tr>
<tr>
<td>Steven Shemesh</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$102.00</td>
<td>$102.00</td>
</tr>
<tr>
<td>Rupesh Parikh</td>
<td>Oppenheimer</td>
<td>Raises</td>
<td>Outperform</td>
<td>$100.00</td>
<td>$95.00</td>
</tr>
<tr>
<td>Bobby Griffin</td>
<td>Raymond James</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$105.00</td>
<td>$115.00</td>
</tr>
<tr>
<td>David Belinger</td>
<td>Mizuho</td>
<td>Announces</td>
<td>Outperform</td>
<td>$105.00</td>
<td>-</td>
</tr>
<tr>
<td>Michael Lasser</td>
<td>UBS</td>
<td>Lowers</td>
<td>Buy</td>
<td>$110.00</td>
<td>$112.00</td>
</tr>
<tr>
<td>Steven Shemesh</td>
<td>RBC Capital</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$102.00</td>
<td>$107.00</td>
</tr>
<tr>
<td>Joseph Feldman</td>
<td>Telsey Advisory Group</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$115.00</td>
<td>$115.00</td>
</tr>
<tr>
<td>Mark Astrachan</td>
<td>Stifel</td>
<td>Lowers</td>
<td>Hold</td>
<td>$91.00</td>
<td>$93.00</td>
</tr>
<tr>
<td>Rupesh Parikh</td>
<td>Oppenheimer</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$95.00</td>
<td>$110.00</td>
</tr>
<tr>
<td>Mark Astrachan</td>
<td>Stifel</td>
<td>Lowers</td>
<td>Hold</td>
<td>$93.00</td>
<td>$99.00</td>
</tr>
<tr>
<td>Greg Melich</td>
<td>Evercore ISI Group</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$100.00</td>
<td>$107.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Walmart. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of Walmart compared to the broader market.</li>
<li>Price Targets: Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.</li>
</ul>
Capture valuable insights into Walmart's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/WMT/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Walmart analyst ratings.</a>
<h2>Discovering Walmart: A Closer Look</h2>
Walmart is a leading retailer in the United States, with its strategy predicated on superior operating efficiency and offering the lowest priced goods to consumers to drive robust store traffic and product turnover. Walmart augmented its low-price business strategy by offering a convenient one-stop shopping destination with the opening of its first supercenter in 1988.Today, Walmart operates over 4,600 stores in the United States (5,200 including Sam's Club) and over 10,000 locations globally. Walmart generated over $460 billion in domestic namesake sales in fiscal 2025, with Sam's Club contributing another $90 billion to the company's top line. Internationally, Walmart generated $120 billion in sales. The retailer serves around 270 million customers globally each week.
<h3>Breaking Down Walmart's Financial Performance</h3>
Market Capitalization Analysis: The company's market capitalization is above the industry average, indicating that it is relatively larger in size compared to peers. This may suggest a higher level of investor confidence and market recognition.
Revenue Growth: Walmart's revenue growth over a period of 3M has faced challenges. As of 30 April, 2025, the company experienced a revenue decline of approximately -8.28%. This indicates a decrease in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Consumer Staples sector.
Net Margin: Walmart's net margin is below industry standards, pointing towards difficulties in achieving strong profitability. With a net margin of 2.71%, the company may encounter challenges in effective cost control.
Return on Equity (ROE): Walmart's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of 5.13%, the company may face hurdles in generating optimal returns for shareholders.
Return on Assets (ROA): Walmart's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of 1.72%, the company may encounter challenges in delivering satisfactory returns from its assets.
Debt Management: With a below-average debt-to-equity ratio of 0.8, Walmart adopts a prudent financial strategy, indicating a balanced approach to debt management.
<h2>The Core of Analyst Ratings: What Every Investor Should Know</h2>
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Forecasting The Future: 20 Analyst Projections For Walmart

Ratings for Plexus (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLXS#NASDAQ">PLXS</a>) were provided by 4 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Insights from analysts' 12-month price targets are revealed, presenting an average target of $160.5, a high estimate of $162.00, and a low estimate of $160.00. This current average represents a 3.02% decrease from the previous average price target of $165.50. 
<img src="https://www.benzinga.com/files/images/story/2025/1749063668_0.png" alt="price target chart" />
<h2>Diving into Analyst Ratings: An In-Depth Exploration</h2>
A comprehensive examination of how financial experts perceive Plexus is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>David Williams</td>
<td>Benchmark</td>
<td>Maintains</td>
<td>Buy</td>
<td>$160.00</td>
<td>$160.00</td>
</tr>
<tr>
<td>David Williams</td>
<td>Benchmark</td>
<td>Maintains</td>
<td>Buy</td>
<td>$160.00</td>
<td>$160.00</td>
</tr>
<tr>
<td>David Williams</td>
<td>Benchmark</td>
<td>Lowers</td>
<td>Buy</td>
<td>$160.00</td>
<td>$170.00</td>
</tr>
<tr>
<td>James Ricchiuti</td>
<td>Needham</td>
<td>Lowers</td>
<td>Buy</td>
<td>$162.00</td>
<td>$172.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Plexus. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Plexus compared to the broader market.</li>
<li>Price Targets: Understanding forecasts, analysts offer estimates for Plexus's future value. Examining the current and prior targets provides insight into analysts' changing expectations.</li>
</ul>
For valuable insights into Plexus's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/PLXS/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Plexus analyst ratings.</a>
<h2>Discovering Plexus: A Closer Look</h2>
Plexus Corp is a U.S based Electronic Manufacturing Services company that provides a range of services, from conceptualization and design to fulfilling orders and providing sustaining solutions, such as replenishment and refurbishment. The company's segments comprise AMER, APAC,ge and EMEA.
<h3>Plexus: A Financial Overview</h3>
Market Capitalization: With restricted market capitalization, the company is positioned below industry averages. This reflects a smaller scale relative to peers.
Revenue Growth: Plexus displayed positive results in 3M. As of 31 March, 2025, the company achieved a solid revenue growth rate of approximately 1.37%. This indicates a notable increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Information Technology sector.
Net Margin: Plexus's net margin is impressive, surpassing industry averages. With a net margin of 3.99%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): Plexus's ROE stands out, surpassing industry averages. With an impressive ROE of 2.93%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): Plexus's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of 1.27%, the company showcases efficient use of assets and strong financial health.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.18.
<h2>Analyst Ratings: Simplified</h2>
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

PLXS

4 Analysts Have This To Say About Plexus

Intl Flavors &amp; Fragrances (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IFF#NYSE">IFF</a>) has been analyzed by 14 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">4</td>
<td align="right">7</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">2</td>
<td align="right">4</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
In the assessment of 12-month price targets, analysts unveil insights for Intl Flavors &amp; Fragrances, presenting an average target of $89.93, a high estimate of $105.00, and a low estimate of $76.00. Highlighting a 5.03% decrease, the current average has fallen from the previous average price target of $94.69. 
<img src="https://www.benzinga.com/files/images/story/2025/1749063658_0.png" alt="price target chart" />
<h2>Investigating Analyst Ratings: An Elaborate Study</h2>
A comprehensive examination of how financial experts perceive Intl Flavors &amp; Fragrances is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Ivan Feinseth</td>
<td>Tigress Financial</td>
<td>Announces</td>
<td>Buy</td>
<td>$105.00</td>
<td>-</td>
</tr>
<tr>
<td>Lisa De Neve</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$98.00</td>
<td>$100.00</td>
</tr>
<tr>
<td>Patrick Cunningham</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Buy</td>
<td>$90.00</td>
<td>$84.00</td>
</tr>
<tr>
<td>Ghansham Panjabi</td>
<td>Baird</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$100.00</td>
<td>$110.00</td>
</tr>
<tr>
<td>Lauren Lieberman</td>
<td>Barclays</td>
<td>Raises</td>
<td>Overweight</td>
<td>$84.00</td>
<td>$76.00</td>
</tr>
<tr>
<td>Joshua Spector</td>
<td>UBS</td>
<td>Raises</td>
<td>Neutral</td>
<td>$83.00</td>
<td>$82.00</td>
</tr>
<tr>
<td>Kristen Owen</td>
<td>Oppenheimer</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$89.00</td>
<td>$104.00</td>
</tr>
<tr>
<td>John Roberts</td>
<td>Mizuho</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$87.00</td>
<td>$95.00</td>
</tr>
<tr>
<td>Lauren Lieberman</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$76.00</td>
<td>$82.00</td>
</tr>
<tr>
<td>Lisa De Neve</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$100.00</td>
<td>$106.00</td>
</tr>
<tr>
<td>Mark Astrachan</td>
<td>Stifel</td>
<td>Lowers</td>
<td>Buy</td>
<td>$91.00</td>
<td>$105.00</td>
</tr>
<tr>
<td>Michael Sison</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$90.00</td>
<td>$105.00</td>
</tr>
<tr>
<td>Patrick Cunningham</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Buy</td>
<td>$84.00</td>
<td>$99.00</td>
</tr>
<tr>
<td>Lauren Lieberman</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$82.00</td>
<td>$83.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Intl Flavors &amp; Fragrances. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of Intl Flavors &amp; Fragrances compared to the broader market.</li>
<li>Price Targets: Analysts predict movements in price targets, offering estimates for Intl Flavors &amp; Fragrances's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Intl Flavors &amp; Fragrances's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/IFF/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Intl Flavors &amp; Fragrances analyst ratings.</a>
<h2>All You Need to Know About Intl Flavors &amp; Fragrances</h2>
International Flavors &amp; Fragrances is the largest specialty ingredients producer globally. It sells ingredients for the food, beverage, health, household goods, personal care, and pharmaceutical industries. The company makes proprietary formulations, partnering with customers to deliver custom solutions. The nourish segment, which generates roughly half of revenue, is a leading flavor producer and also sell texturants, plant-based proteins, and other ingredients. The health and biosciences business, which generates around one fourth of revenue, is a global leader in probiotics and enzymes. IFF is also one of the leading fragrance producers in the world.
<h3>Understanding the Numbers: Intl Flavors &amp; Fragrances's Finances</h3>
Market Capitalization Highlights: Above the industry average, the company's market capitalization signifies a significant scale, indicating strong confidence and market prominence.
Decline in Revenue: Over the 3M period, Intl Flavors &amp; Fragrances faced challenges, resulting in a decline of approximately -1.93% in revenue growth as of 31 March, 2025. This signifies a reduction in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Materials sector.
Net Margin: Intl Flavors &amp; Fragrances's net margin lags behind industry averages, suggesting challenges in maintaining strong profitability. With a net margin of -35.81%, the company may face hurdles in effective cost management.
Return on Equity (ROE): The company's ROE is below industry benchmarks, signaling potential difficulties in efficiently using equity capital. With an ROE of -7.53%, the company may need to address challenges in generating satisfactory returns for shareholders.
Return on Assets (ROA): Intl Flavors &amp; Fragrances's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of -3.58%, the company may encounter challenges in delivering satisfactory returns from its assets.
Debt Management: Intl Flavors &amp; Fragrances's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.75.
<h2>The Core of Analyst Ratings: What Every Investor Should Know</h2>
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

14 Analysts Have This To Say About Intl Flavors & Fragrances

In the last three months, 21 analysts have published ratings on eBay (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EBAY#NASDAQ">EBAY</a>), offering a diverse range of perspectives from bullish to bearish.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">2</td>
<td align="right">5</td>
<td align="right">14</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">2</td>
<td align="right">5</td>
<td align="right">11</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $68.24, along with a high estimate of $79.00 and a low estimate of $54.00. Marking an increase of 3.39%, the current average surpasses the previous average price target of $66.00. 
<img src="https://www.benzinga.com/files/images/story/2025/1749063640_0.png" alt="price target chart" />
<h2>Analyzing Analyst Ratings: A Detailed Breakdown</h2>
The perception of eBay by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Doug Anmuth</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Neutral</td>
<td>$66.00</td>
<td>$60.00</td>
</tr>
<tr>
<td>Shyam Patil</td>
<td>Susquehanna</td>
<td>Raises</td>
<td>Neutral</td>
<td>$70.00</td>
<td>$65.00</td>
</tr>
<tr>
<td>Nathan Feather</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Overweight</td>
<td>$74.00</td>
<td>$70.00</td>
</tr>
<tr>
<td>Deepak Mathivanan</td>
<td>Cantor Fitzgerald</td>
<td>Raises</td>
<td>Neutral</td>
<td>$69.00</td>
<td>$65.00</td>
</tr>
<tr>
<td>Doug Anmuth</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Neutral</td>
<td>$60.00</td>
<td>$54.00</td>
</tr>
<tr>
<td>John Blackledge</td>
<td>TD Securities</td>
<td>Raises</td>
<td>Hold</td>
<td>$64.00</td>
<td>$62.00</td>
</tr>
<tr>
<td>Mark Kelley</td>
<td>Stifel</td>
<td>Raises</td>
<td>Hold</td>
<td>$62.00</td>
<td>$61.00</td>
</tr>
<tr>
<td>Youssef Squali</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Hold</td>
<td>$68.00</td>
<td>$62.00</td>
</tr>
<tr>
<td>Ross Sandler</td>
<td>Barclays</td>
<td>Raises</td>
<td>Overweight</td>
<td>$77.00</td>
<td>$72.00</td>
</tr>
<tr>
<td>Ken Gawrelski</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$63.00</td>
<td>$62.00</td>
</tr>
<tr>
<td>Thomas Champion</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Overweight</td>
<td>$74.00</td>
<td>$70.00</td>
</tr>
<tr>
<td>Mark Mahaney</td>
<td>Evercore ISI Group</td>
<td>Raises</td>
<td>In-Line</td>
<td>$69.00</td>
<td>$63.00</td>
</tr>
<tr>
<td>Colin Sebastian</td>
<td>Baird</td>
<td>Raises</td>
<td>Outperform</td>
<td>$75.00</td>
<td>$68.00</td>
</tr>
<tr>
<td>Bernie McTernan</td>
<td>Needham</td>
<td>Raises</td>
<td>Buy</td>
<td>$78.00</td>
<td>$72.00</td>
</tr>
<tr>
<td>Kunal Madhukar</td>
<td>UBS</td>
<td>Raises</td>
<td>Neutral</td>
<td>$73.00</td>
<td>$72.00</td>
</tr>
<tr>
<td>Ygal Arounian</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Buy</td>
<td>$79.00</td>
<td>$80.00</td>
</tr>
<tr>
<td>Mark Kelley</td>
<td>Stifel</td>
<td>Lowers</td>
<td>Hold</td>
<td>$61.00</td>
<td>$63.00</td>
</tr>
<tr>
<td>Nikhil Devnani</td>
<td>Bernstein</td>
<td>Lowers</td>
<td>Market Perform</td>
<td>$65.00</td>
<td>$70.00</td>
</tr>
<tr>
<td>Nathan Feather</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$70.00</td>
<td>$71.00</td>
</tr>
<tr>
<td>Doug Anmuth</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$54.00</td>
<td>$60.00</td>
</tr>
<tr>
<td>Ken Gawrelski</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$62.00</td>
<td>$64.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to eBay. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of eBay compared to the broader market.</li>
<li>Price Targets: Analysts explore the dynamics of price targets, providing estimates for the future value of eBay's stock. This examination reveals shifts in analysts' expectations over time.</li>
</ul>
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into eBay's market standing. Stay informed and make well-considered decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/EBAY/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on eBay analyst ratings.</a>
<h2>Delving into eBay's Background</h2>
EBay operates one of the largest e-commerce marketplaces in the world, with $75 billion in 2024 gross merchandise volume rendering the firm a top 10 global e-commerce company. It generates revenue from listing fees, advertising, revenue-sharing arrangements with service providers, and managed payments, with its platform connecting more than 130 million buyers and roughly 20 million sellers across almost 190 global markets at the end of 2024. EBay generates just north of 50% of its GMV in international markets, with a large presence in the UK, Germany, and Australia.
<h3>eBay: Financial Performance Dissected</h3>
Market Capitalization Analysis: The company exhibits a lower market capitalization profile, positioning itself below industry averages. This suggests a smaller scale relative to peers.
Positive Revenue Trend: Examining eBay's financials over 3M reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 1.13% as of 31 March, 2025, showcasing a substantial increase in top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Consumer Discretionary sector.
Net Margin: eBay's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 19.46%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): eBay's ROE stands out, surpassing industry averages. With an impressive ROE of 9.95%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 2.63%, the company showcases effective utilization of assets.
Debt Management: With a high debt-to-equity ratio of 1.45, eBay faces challenges in effectively managing its debt levels, indicating potential financial strain.
<h2>The Basics of Analyst Ratings</h2>
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

EBAY

A Glimpse Into The Expert Outlook On eBay Through 21 Analysts

In the preceding three months, 16 analysts have released ratings for Rockwell Automation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ROK#NYSE">ROK</a>), presenting a wide array of perspectives from bullish to bearish.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">3</td>
<td align="right">5</td>
<td align="right">7</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">4</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $295.25, a high estimate of $371.00, and a low estimate of $201.00. This upward trend is apparent, with the current average reflecting a 4.72% increase from the previous average price target of $281.94.
<img src="https://www.benzinga.com/files/images/story/2025/1749063631_0.png" alt="price target chart" />
<h2>Investigating Analyst Ratings: An Elaborate Study</h2>
An in-depth analysis of recent analyst actions unveils how financial experts perceive Rockwell Automation. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Andrew Kaplowitz</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Buy</td>
<td>$371.00</td>
<td>$327.00</td>
</tr>
<tr>
<td>Julian Mitchell</td>
<td>Barclays</td>
<td>Raises</td>
<td>Overweight</td>
<td>$350.00</td>
<td>$283.00</td>
</tr>
<tr>
<td>Stephen Tusa</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Neutral</td>
<td>$299.00</td>
<td>$271.00</td>
</tr>
<tr>
<td>Chris Dankert</td>
<td>Loop Capital</td>
<td>Raises</td>
<td>Hold</td>
<td>$290.00</td>
<td>$280.00</td>
</tr>
<tr>
<td>Andrew Kaplowitz</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Buy</td>
<td>$327.00</td>
<td>$283.00</td>
</tr>
<tr>
<td>Julian Mitchell</td>
<td>Barclays</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$283.00</td>
<td>$260.00</td>
</tr>
<tr>
<td>Ken Newman</td>
<td>Keybanc</td>
<td>Raises</td>
<td>Overweight</td>
<td>$330.00</td>
<td>$275.00</td>
</tr>
<tr>
<td>Noah Kaye</td>
<td>Oppenheimer</td>
<td>Raises</td>
<td>Outperform</td>
<td>$304.00</td>
<td>$258.00</td>
</tr>
<tr>
<td>Joseph O'Dea</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$315.00</td>
<td>$265.00</td>
</tr>
<tr>
<td>Stephen Tusa</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Neutral</td>
<td>$271.00</td>
<td>$201.00</td>
</tr>
<tr>
<td>Andrew Kaplowitz</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Buy</td>
<td>$283.00</td>
<td>$350.00</td>
</tr>
<tr>
<td>Julian Mitchell</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$260.00</td>
<td>$280.00</td>
</tr>
<tr>
<td>Stephen Tusa</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Underweight</td>
<td>$201.00</td>
<td>$248.00</td>
</tr>
<tr>
<td>Ken Newman</td>
<td>Keybanc</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$275.00</td>
<td>$345.00</td>
</tr>
<tr>
<td>Julian Mitchell</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$280.00</td>
<td>$285.00</td>
</tr>
<tr>
<td>Julian Mitchell</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$285.00</td>
<td>$300.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Rockwell Automation. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of Rockwell Automation compared to the broader market.</li>
<li>Price Targets: Analysts gauge the dynamics of price targets, providing estimates for the future value of Rockwell Automation's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
For valuable insights into Rockwell Automation's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/ROK/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Rockwell Automation analyst ratings.</a>
<h2>About Rockwell Automation</h2>
With roots tracing back to the early 1900s, Rockwell Automation is the successor to Rockwell International, which spun off its avionics segment in 2001. It is a pure-play industrial automation company that operates through three segments. Its largest segment by revenue, intelligent devices, sells factory floor-level devices such as motors, drives, sensors, relays, and actuators. Its software and control segment sells visualization, simulation, and human-machine interface software and control products such as programmable controllers, computers, and operator terminals. Its smallest segment, lifecycle services, offers digital consulting, engineered-to-order services, and other outsourced services such as remote monitoring, cybersecurity, and asset and plant maintenance and optimization.
<h3>Financial Milestones: Rockwell Automation's Journey</h3>
Market Capitalization Highlights: Above the industry average, the company's market capitalization signifies a significant scale, indicating strong confidence and market prominence.
Revenue Growth: Rockwell Automation's revenue growth over a period of 3M has faced challenges. As of 31 March, 2025, the company experienced a revenue decline of approximately -5.88%. This indicates a decrease in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Industrials sector.
Net Margin: Rockwell Automation's net margin excels beyond industry benchmarks, reaching 12.54%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): Rockwell Automation's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 7.36% ROE, the company effectively utilizes shareholder equity capital.
Return on Assets (ROA): Rockwell Automation's ROA stands out, surpassing industry averages. With an impressive ROA of 2.29%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: The company faces challenges in debt management with a debt-to-equity ratio higher than the industry average. With a ratio of 1.19, caution is advised due to increased financial risk.
<h2>How Are Analyst Ratings Determined?</h2>
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Breaking Down Rockwell Automation: 16 Analysts Share Their Views

Looking into the current session, Fidelity National Finl Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FNF#NYSE">FNF</a>) shares are trading at $54.50, after a 0.29% decrease. Over the past month, the stock fell by 15.34%, but over the past year, it actually spiked by 9.56%. With questionable short-term performance like this, and great long-term performance, long-term shareholders might want to start looking into the company's price-to-earnings ratio. 

<img src="https://www.benzinga.com/files/images/story/2025/1749063630_0.png" alt="Past Year Chart" />

<h3>Fidelity National Finl P/E Compared to Competitors</h3>
The P/E ratio measures the current share price to the company's EPS. It is used by long-term investors to analyze the company's current performance against it's past earnings, historical data and aggregate market data for the industry or the indices, such as S&amp;P 500. A higher P/E indicates that investors expect the company to perform better in the future, and the stock is probably overvalued, but not necessarily. It also could indicate that investors are willing to pay a higher share price currently, because they expect the company to perform better in the upcoming quarters. This leads investors to also remain optimistic about rising dividends in the future. 
Fidelity National Finl has a lower P/E than the aggregate P/E of 24.34 of the Insurance industry. Ideally, one might believe that the stock might perform worse than its peers, but it's also probable that the stock is undervalued. 

<img src="https://www.benzinga.com/files/images/story/2025/1749063630_1.png" alt="Guage" />

In summary, while the price-to-earnings ratio is a valuable tool for investors to evaluate a company's market performance, it should be used with caution. A low P/E ratio can be an indication of undervaluation, but it can also suggest weak growth prospects or financial instability. Moreover, the P/E ratio is just one of many metrics that investors should consider when making investment decisions, and it should be evaluated alongside other financial ratios, industry trends, and qualitative factors. By taking a comprehensive approach to analyzing a company's financial health, investors can make well-informed decisions that are more likely to lead to successful outcomes.

Intraday Update

Price Over Earnings Overview: Fidelity National Finl

Boston Scientific's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BSX#NYSE">BSX</a>) short percent of float has risen 6.6% since its last report. The company recently reported that it has 16.75 million shares sold short, which is 1.13% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.77 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Boston Scientific Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1749063629_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Boston Scientific has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Boston Scientific's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Boston Scientific's peer group average for short interest as a percentage of float is 5.51%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

Is Boston Scientific Gaining or Losing Market Support?

Press Releases

CORRECTION -- Rapport Therapeutics Announces New Phase 1 Data, Further Supporting RAP-219's Transformative Potential for CNS Disorders

Rapport Therapeutics to Participate in Upcoming Investor Conferences

Rapport Therapeutics Announces Appointment of Dr. Jeffrey Sevigny as Chief Medical Officer to Drive Clinical Strategy and Precision Medicine Development

Comments

Rapport Therapeutics

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL